Brain stimulation to help memory in mild cognitive impairment
Tests gentle electrical brain stimulation against a sham version in older adults with memory problems.
Key facts
- Who runs it
- Lucie Bréchet
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Improvement of Memory in Mild Cognitive Impairment
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 1 Feb 2023
- Expected to end
- 1 Dec 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- transcranial alternating current stimulation (tACS)
- high-density electroencephalography (hdEEG)
- Montreal Cognitive Assessment (MoCA)
- Record updated
- 15 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 or older with mild cognitive impairment (MCI), a mild memory and thinking problem. Each patient joins with a caregiver who gives a mild brain stimulation (tACS) at home.
- Age
- Patients: 55 Years to 85 Years. Caregivers: at least 21 years.
- Sex
- All sexes can join.
- Disease stage
- A clinical diagnosis of mild cognitive impairment (MCI), based on a full clinical check and memory and thinking tests. The study doctor confirms the diagnosis.
Main reasons for not taking part
- A current psychiatric disorder, or another brain or nerve disease such as Parkinson's disease, stroke or a brain tumor
- Seizures or epilepsy, or head injury with long loss of consciousness
- Metal in the head or body, or implanted devices such as a pacemaker, or anything that rules out MRI or tACS
- Skin problems such as dermatitis, psoriasis or eczema, or a serious life-threatening disease
- Pregnant women, or adults who cannot give consent
The registry criteria, word for word
Show all 32 criteriaShow less
Who can take part
- Mild Cognitive Impairment (MCI) patients
- age ≥ 55 years old
- clinical diagnosis of mild cognitive impairment (MCI) based on a comprehensive clinical assessment and standard neuropsychological examination including tests of language, visuospatial thinking, executive functions, and memory
- confirmation of diagnosis will be made by Prof. Paul Unschuld, the study MD, based on a participant's cognitive evaluation and history
- understanding of the informed consent
- able and willing to comply with all study requirements
- informed consent form was signed
- women of childbearing potential (WOCBP) must perform a pregnancy test during screening; Caregiver
- minimum 21 years of age
- self-reported computer/tablet proficiency
- willingness to learn how to use tACS
- availability during the study period to administer tACS to the participant
- informed consent form was signed
- women of childbearing potential (WOCBP) must perform a pregnancy test during screening
Who cannot take part
- contraindication for undergoing MRI or receiving tACS
- any electrically, magnetically, or mechanically activated implanted devices such as a pacemaker, intracranial electrodes, implanted defibrillators, medication pumps, nerve stimulators, vascular clips, or any other prosthesis in the brain
- Mild Cognitive Impairment (MCI) patients
- any current diagnosis of a psychiatric disorder (e.g., schizophrenia, bipolar disorder, depressive disorder)
- other than MCI, any history of other progressive or genetic neurologic disorder (e.g., Parkinson's disease, multiple sclerosis, tubular sclerosis) or acquired neurological disease (e.g., stroke, traumatic brain injury, tumor), including intracranial lesions
- history of head trauma resulting in prolonged loss of consciousness
- current history of poorly controlled headaches including chronic medication for migraine prevention
- history of fainting spells of unknown or undetermined etiology that might constitute seizures
- history of seizures, diagnosis of epilepsy
- any unstable medical condition or chronic uncontrolled medical conditions that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.)
- any serious life-threatening disease such as congestive heart failure, pulmonary obstructive chronic disease, or active neoplasia
- poor eyesight, severe arthritis in the hands, pain, deformity or other condition that interferes with successful administration of tACS
- age < 55 years old
- any metal in the brain or skull (excluding dental fillings) or elsewhere in the body unless cleared by the responsible covering MD (e.g., MRI compatible joint replacement)
- any skin problems, such as dermatitis, psoriasis, or eczema
- pregnant women
- adults lacking capacity for consent; Caregiver
- insufficient understanding of study procedures
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The Clinical Trial will systematically examine the feasibility of remote, caregiver-led tACS for older adults with memory deficits and evaluate whether repeated tACS leads to sustained improvement of neuronal activity and memory functions.
The 3 groups in the trial
- Transcranial alternating current stimulation (tACS)Treatment being tested
The randomized, sham-controlled, parallel-arm, double-blind clinical trial will include 4 weeks of daily, home-based stimulation sessions. MCI patients will be randomly assigned to the active or sham group.
- neurophysiological (hdEEG)Treatment being tested
At the baseline and after 4 weeks, MCI patients will be evaluated in the laboratory using hdEEG.
Treatment: high-density electroencephalography (hdEEG)
- clinical measures (MoCA)Treatment being tested
At the baseline and after 4 weeks, MCI patients will be evaluated in the laboratory using MoCA.
Treatment: Montreal Cognitive Assessment (MoCA)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improvement of Memory in Mild Cognitive Impairment (MCI) Using Transcranial Alternating Current Stimulation (tACS) Guided by EEG and MRI: a Randomized, Sham-controlled, Parallel-arm, Double-blind Study
- Plain-language title
- Brain stimulation to help memory in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05708001, who can take part
- Publications
- Personalized, home-based transcranial alternating current stimulation for memory improvement in mild cognitive impairment: randomized, sham-controlled clinical trial protocol.Frontiers in aging neuroscience, 2026
- Family caregiver perspectives on administering home-based stimulation in patients with mild cognitive impairment.Journal of Alzheimer's disease : JAD, 2026
- Record updated
- 15 July 2025